|
|
Post by kc on Feb 1, 2015 23:34:59 GMT -5
I would not worry about prescription numbers for 6 or 8 months. This is a ultra marathon and we just begin the race.
|
|
|
|
Demand
Feb 1, 2015 23:53:42 GMT -5
Post by dreamboatcruise on Feb 1, 2015 23:53:42 GMT -5
I would not worry about prescription numbers for 6 or 8 months. This is a ultra marathon and we just begin the race. For better or worse, analysts are likely to start comparing the numbers to previous drug launches. |
|
dean
Newbie
l
Posts: 21 
|
Demand
Feb 2, 2015 0:12:34 GMT -5
Post by dean on Feb 2, 2015 0:12:34 GMT -5
I would not worry about prescription numbers for 6 or 8 months. This is a ultra marathon and we just begin the race. For better or worse, analysts are likely to start comparing the numbers to previous drug launches. very true dreamboatcruise. for instance, analysts and investors both big and small were on top of vivus weekly script numbers like white on rice. and vivus pps fell with each week's scripts not meeting expectations. |
|
|
|
Demand
Feb 2, 2015 11:41:32 GMT -5
Post by primarygp on Feb 2, 2015 11:41:32 GMT -5
As someone who was involved with Exubera, I can state that Pfizer definitely miscalculated the spirometry requirement. With 30% of GP’s and 0% of Endo’s utilizing spirometry in their practice, the majority of patients had to be referred to pulmonologists; who were not pleased to be testing asymptomatic diabetes patients. Spirometry is not as easy as drawing blood or performing an x-ray, it requires patient effort and cooperation.
Giving spirometers (which are reimbursable) to physicians is not an option or Pfizer would have done so. From what I’m hearing here, it doesn’t appear SNY has yet addressed this impediment.
|
|
|
|
Post by joeypotsandpans on Feb 2, 2015 11:59:56 GMT -5
As someone who was involved with Exubera, I can state that Pfizer definitely miscalculated the spirometry requirement. With 30% of GP’s and 0% of Endo’s utilizing spirometry in their practice, the majority of patients had to be referred to pulmonologists; who were not pleased to be testing asymptomatic diabetes patients. Spirometry is not as easy as drawing blood or performing an x-ray, it requires patient effort and cooperation. Giving spirometers (which are reimbursable) to physicians is not an option or Pfizer would have done so. From what I’m hearing here, it doesn’t appear SNY has yet addressed this impediment. Two things regarding this statement, first my wife who is an ICU RN for 30yrs (and I'm sure the other RN's on this board will confirm) found this laughable as a she stated a spirometry test is one of the easiest tests to conduct and perform and for any GP/endo who has difficulty with it, she would hate to see what other issues they have performing tasks that are a tad more difficult. Second, just curious as you happened to be posting on this board and went through the time and effort to register (about the same time it takes to perform the test btw) and do you have a financial position or did you go out of your way to just throw your two cents in, and are you really a primary gp....also are you on the YMB as well...and are you "hearing" those non addressed impediment statements from SNY reps themselves...thanks in advance. |
|
|
|
Post by kharans on Feb 2, 2015 12:04:04 GMT -5
The drugs you are taking are too strong. Taking blood is by far more discomfortable and frequently leaves the patient with a hematom or requires multiple tries to hit the vain. By any diagnostical procedure the patient has to cooperate either by standing still, beeing in a certain position or by breathing in an instructed way. Spirometry is a quick and painless procedure, which in Europe does not even require the presence of a doctor, it is performed by a nurse. I have even done it as a nursing student...
|
|
|
|
Post by gomnkd on Feb 2, 2015 12:09:21 GMT -5
I've taken spirometry test during a physical. You blow air into a friggin tube. How hard is that?
|
|
|
|
Demand
Feb 2, 2015 12:18:37 GMT -5
Post by od on Feb 2, 2015 12:18:37 GMT -5
As someone who was involved with Exubera, I can state that Pfizer definitely miscalculated the spirometry requirement. With 30% of GP’s and 0% of Endo’s utilizing spirometry in their practice, the majority of patients had to be referred to pulmonologists; who were not pleased to be testing asymptomatic diabetes patients. Spirometry is not as easy as drawing blood or performing an x-ray, it requires patient effort and cooperation. Giving spirometers (which are reimbursable) to physicians is not an option or Pfizer would have done so. From what I’m hearing here, it doesn’t appear SNY has yet addressed this impediment. Two things regarding this statement, first my wife who is an ICU RN for 30yrs (and I'm sure the other RN's on this board will confirm) found this laughable as a she stated a spirometry test is one of the easiest tests to conduct and perform and for any GP/endo who has difficulty with it, she would hate to see what other issues they have performing tasks that are a tad more difficult. Second, just curious as you happened to be posting on this board and went through the time and effort to register (about the same time it takes to perform the test btw) and do you have a financial position or did you go out of your way to just throw your two cents in, and are you really a primary gp....also are you on the YMB as well...and are you "hearing" those non addressed impediment statements from SNY reps themselves...thanks in advance. Ouch. While I agree spirometry testing is easy, and perhaps primarygp was a bit heavy handed with that comment, I think the message was about spirometer penetration in GP and Endo offices, and how it will delay NRxs. I believe interested investor's diligence should be similar to SNY's, and if it is accurate that provider detailing includes explaining lung function testing reimbursement, then I think it is fair to believe that they are addressing what they know was an impediment to Exubera sales. If Afrezza is the product we all believe/know it is, spirometer penetration will resolve itself. That said, today, this week, this month, too many patients will leave their first office visit re: Afrezza without a prescription. I agree with those that understand Afrezza's success will not happen overnight, but will happen sooner than later. |
|
|
|
Demand
Feb 2, 2015 12:43:05 GMT -5
Post by spiro on Feb 2, 2015 12:43:05 GMT -5
|
|
|
|
Post by brentie on Feb 2, 2015 12:53:09 GMT -5
|
|
|
|
Demand
Feb 2, 2015 12:58:29 GMT -5
Post by cybergym66 on Feb 2, 2015 12:58:29 GMT -5
Spiro, $50 or so for this spirometry...THIS is what's shorts think is going to prevent diabetics from getting Afrezza?! I'm a lot less worried now! I'm not a doctor, but only play one with my wife!, but that spirometry looks like it will do the trick! |
|
|
|
Demand
Feb 2, 2015 13:16:56 GMT -5
Post by od on Feb 2, 2015 13:16:56 GMT -5
Great idea, and though I am not sure...I believe reimbursement requires full lung function testing, not just FEV1 (yes, I know black box only calls for FEV1), and for Afrezza, in addition to the raw FEV1 value the device must calculate the percent of the predicted value. Looking at this it appears to only provide raw value and it does not have FDA 501(k) clearance. |
|
|
|
Post by 4allthemarbles on Feb 2, 2015 13:35:10 GMT -5
This still seems like a non- issue to me. Look, there are still PCP offices that send patients out to have blood drawn (think Labcorp). I have also done the "blow in the tube" test. NON- ISSUE.
The real enemy is miseducation and time. Meaning, someone will always have their spin as to why this drug is going to end the world and if you use it, you could be dead in a year. Most of this people either have a financial interest in the drug failing or refuse to change, because change is evil.
Time just takes time- meaning, look at how many docs have been trained in two to three weeks. Weeks. Then the patient adaption will take time. The more time that goes on, the less miseducation and time become. Education on the drug becomes wide spread. Usage increases.
The only thing we are waiting for is time under our belts. When the Docs and nurses on the board Are comfortable with this process, it's a matter of time before everyone else is a s well.
In two years, or less, people are going to need another company to trash unfairly. The science works.
|
|
|
|
Demand
Feb 2, 2015 13:39:48 GMT -5
Post by od on Feb 2, 2015 13:39:48 GMT -5
I think we all agree spirometry testing is as simple as it gets. I think we all agree it would be great if every practice had a spirometer. I think we all agree that we look forward to the day Afrezza's black box is in the rear view mirror. I am sure SNY and MNKD agree!
|
|
|
|
Demand
Feb 2, 2015 16:37:38 GMT -5
Post by suebeeee1 on Feb 2, 2015 16:37:38 GMT -5
LOL, my husband, who has Type 2 is practicing with one for his drs appt! |
|
